威高股份：威高骨科前三季度归母净利润2.07亿元 同比增加26.24%

Core Viewpoint - Weigao Co., Ltd. reported a steady performance in its orthopedic segment, with revenue growth and significant profit increase in the third quarter of 2024 [1] Financial Performance - The company achieved a revenue of 1.106 billion yuan in the first three quarters, representing a year-on-year increase of 2.12% [1] - The net profit attributable to shareholders reached 207 million yuan, marking a year-on-year increase of 26.24% [1] - Basic earnings per share were reported at 0.52 yuan [1] Market Dynamics - The overall execution of bulk purchasing in orthopedics remained stable during the reporting period [1] - The market share of leading domestic brands in the orthopedic sector continued to rise [1] Strategic Initiatives - The company is undergoing a transformation in its sales model, focusing on professional departments for business unit division [1] - Efforts to optimize and upgrade the marketing structure have been implemented, enhancing the professionalism and flexibility of the sales team [1] - These initiatives have led to sustained growth in revenue and sales volume across product lines [1]